Skip to content

Drug interactions

Pazopanib + Simvastatin

Severity: Moderate

Pazopanib and Simvastatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pazopanib inhibits OATP1B1 and can raise simvastatin exposure, and the combination has been associated with a higher frequency of ALT elevations. Both hepatotoxicity and myopathy are therefore concerns.

What this interaction means in plain words

Pazopanib and Simvastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pazopanib belongs to Oncology; Simvastatin belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Pazopanib inhibits OATP1B1 and possibly CYP3A4, increasing simvastatin exposure, with additive hepatic effects.

What to do

Monitor liver function tests regularly and watch for muscle symptoms. Consider a different statin or holding simvastatin if ALT rises.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pazopanib and Simvastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pazopanib with Simvastatin?

MediHelp rates the interaction as moderate. Pazopanib and Simvastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pazopanib inhibits OATP1B1 and can raise simvastatin exposure, and the combination has been associated with a higher frequency of ALT elevations. Both hepatotoxicity and myopathy are therefore concerns.

How serious is the interaction between Pazopanib and Simvastatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver function tests regularly and watch for muscle symptoms. Consider a different statin or holding simvastatin if ALT rises.

What other medicines interact with Simvastatin?

MediHelp also lists interactions of Simvastatin with, for example, Atazanavir, Clarithromycin, Cobicistat. The full list is on the Simvastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in